Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Influenza
French (FR)
NITAG documentation
Americas
Clear all
Type of publications
NITAG documentation
(11)
Topics
Background paper
(5)
Recommendation
(6)
Available to download in languages
French (FR)
(11)
English (EN)
(58)
Spanish (ES)
(7)
Regions
Americas
(11)
Europe
(41)
Countries
Canada
(11)
Diseases
Influenza
(11)
COVID-19
(8)
Diphtheria
(2)
Hepatitis B
(1)
Human papillomavirus (HPV)
(3)
Measles
(1)
Meningococcal disease
(2)
Mumps
(1)
Pertussis
(2)
Rubella
(1)
Varicella
(4)
Vaccine topics
Target population
Publication date
2018
(3)
2017
(1)
2016
(2)
2015
(3)
2014
(2)
11 results found
2018
∙
NACI
Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2018–2019
2018
∙
NACI
Literature Review on Individuals with Neurologic or Neurodevelopment Conditions and Risk of Serious Influenza-Related Complications
2018
∙
NACI
Literature Review Update on the Efficacy and Effectiveness of High-Dose (Fluzone® High-Dose) and MF59-Adjuvanted (Fluad®) Trivalent Inactivated Influenza Vaccines in Adults 65 Years of Age and Older
2017
∙
NACI
National Advisory Committee on Immunization (NACI): Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2017–2018
2016
∙
NACI
ADDENDUM - LAIV Use in Children and Adolescents
2016
∙
NACI
ADDENDUM - LAIV Use in Egg Allergic Individuals Advisory Committee Statement (ACS)
2015
∙
NACI
Literature Review on Pediatric Fluad® Influenza Vaccine Use in Children 6-72 Months of Age
2015
∙
NACI
NACI Opinion on LAIV Effectiveness in Young Children
2015
∙
NACI
Statement on Seasonal Influenza Vaccine for 2015-2016
2014
∙
NACI
Literature review on influenza vaccination in healthy 5-18-year-olds
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register